159 related articles for article (PubMed ID: 38661242)
1. Vogt-Koyanagi-Harada disease after SARS-CoV-2 infection: Case report and literature review.
Zou H; Zhang K; Chen X; Sha S
Immun Inflamm Dis; 2024 Apr; 12(4):e1250. PubMed ID: 38661242
[TBL] [Abstract][Full Text] [Related]
2. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
3. Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases.
de Queiroz Tavares Ferreira F; Araújo DC; de Albuquerque LM; Bianchini PM; Holanda EC; Pugliesi A
Ocul Immunol Inflamm; 2023 Aug; 31(6):1134-1140. PubMed ID: 35914285
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of previously controlled Vogt-Koyanagi-Harada disease more than 46 years following COVID-19 vaccination: a case study.
Muto T; Sakamoto M; Imaizumi S; Kamoi K
J Int Med Res; 2024 Jan; 52(1):3000605231221081. PubMed ID: 38170955
[TBL] [Abstract][Full Text] [Related]
5. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report.
Niidome S; Usui Y; Tsubota K; Sugawara R; Goto H
Ocul Immunol Inflamm; 2023 Aug; 31(6):1305-1309. PubMed ID: 37084286
[TBL] [Abstract][Full Text] [Related]
7. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
Joo CW; Kim YK; Park SP
Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 among the Potential Viral Triggers for Vogt-Konayagi-Harada Disease: First Case Report and Literature Review.
Santamaria A; Chang J; Savarain C
Ocul Immunol Inflamm; 2022; 30(7-8):1869-1875. PubMed ID: 34436960
[TBL] [Abstract][Full Text] [Related]
9. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
[TBL] [Abstract][Full Text] [Related]
10. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
Accorinti M; Saturno MC; Manni P
Ocul Immunol Inflamm; 2022 Jul; 30(5):1228-1233. PubMed ID: 35201950
[TBL] [Abstract][Full Text] [Related]
12. Bilateral acute angle closure glaucoma as an initial presentation of Vogt-Koyanagi-Harada syndrome: A clinical case report.
Yuan F; Zhang Y; Yan X
Eur J Ophthalmol; 2022 Jan; 32(1):NP230-NP234. PubMed ID: 32811185
[TBL] [Abstract][Full Text] [Related]
13. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine.
De Domingo B; López M; Lopez-Valladares M; Ortegon-Aguilar E; Sopeña-Perez-Argüelles B; Gonzalez F
Cells; 2022 Mar; 11(6):. PubMed ID: 35326462
[TBL] [Abstract][Full Text] [Related]
15. Vogt-Koyanagi-Harada Disease and COVID.
Manni P; Saturno MC; Accorinti M
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834885
[TBL] [Abstract][Full Text] [Related]
16. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab.
Su E; Oza VS; Latkany P
J Formos Med Assoc; 2019 May; 118(5):945-950. PubMed ID: 30616991
[TBL] [Abstract][Full Text] [Related]
17. Vogt Koyanagi Harada disease following a recent COVID-19 infection.
Anthony E; Rajamani A; Baskaran P; Rajendran A
Indian J Ophthalmol; 2022 Feb; 70(2):670-672. PubMed ID: 35086262
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Nakayama M; Keino H; Watanabe T; Okada AA
Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
[TBL] [Abstract][Full Text] [Related]
19. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan.
Herbort CP; Mochizuki M
Int Ophthalmol; 2007; 27(2-3):67-79. PubMed ID: 17468832
[TBL] [Abstract][Full Text] [Related]
20. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Manethova K; Ernest J; Hrevus M
Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
